Lanean...
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
INTRODUCTION: It has been argued that tapentadol may pharmacologically have lower abuse potential than other pharmaceutical opioids currently available. However, there has been no comprehensive triangulation of data regarding use and harms associated with this formulation. A sustained-release formul...
Gorde:
| Argitaratua izan da: | BMJ Open |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5875643/ https://ncbi.nlm.nih.gov/pubmed/29574444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-020006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|